Report Detail

Request for Sample of this report

Pharma & Healthcare Global Pediatric Orphan Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4772625
    • |
  • 06 November, 2026
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pediatric Orphan Drug market size was valued at US$ 88160 million in 2025 and is forecast to a readjusted size of US$ 185370 million by 2032 with a CAGR of 11.3% during review period.
Orphan drug development is crucial for children, who are disproportionately affected by rare diseases.
This report is a detailed and comprehensive analysis for global Pediatric Orphan Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pediatric Orphan Drug market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Pediatric Orphan Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Pediatric Orphan Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Pediatric Orphan Drug market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pediatric Orphan Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pediatric Orphan Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca, Takeda, Vertex Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pediatric Orphan Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oncology
Pulmonary
Neurology
Hematology
Endocrinology
Cardio-vascular
Metabolic Disorders
Others
Market segment by Application
0-1 Years
1-3 Years
3-6 Years
6-12 Years
＞ 12 Years
Major players covered
Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pediatric Orphan Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pediatric Orphan Drug, with price, sales quantity, revenue, and global market share of Pediatric Orphan Drug from 2021 to 2026.
Chapter 3, the Pediatric Orphan Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pediatric Orphan Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pediatric Orphan Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pediatric Orphan Drug.
Chapter 14 and 15, to describe Pediatric Orphan Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pediatric Orphan Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Oncology
    • 1.3.3 Pulmonary
    • 1.3.4 Neurology
    • 1.3.5 Hematology
    • 1.3.6 Endocrinology
    • 1.3.7 Cardio-vascular
    • 1.3.8 Metabolic Disorders
    • 1.3.9 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pediatric Orphan Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 0-1 Years
    • 1.4.3 1-3 Years
    • 1.4.4 3-6 Years
    • 1.4.5 6-12 Years
    • 1.4.6 ＞ 12 Years
  • 1.5 Global Pediatric Orphan Drug Market Size & Forecast
    • 1.5.1 Global Pediatric Orphan Drug Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pediatric Orphan Drug Sales Quantity (2021-2032)
    • 1.5.3 Global Pediatric Orphan Drug Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bristol-Myers Squibb
    • 2.1.1 Bristol-Myers Squibb Details
    • 2.1.2 Bristol-Myers Squibb Major Business
    • 2.1.3 Bristol-Myers Squibb Pediatric Orphan Drug Product and Services
    • 2.1.4 Bristol-Myers Squibb Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche Pediatric Orphan Drug Product and Services
    • 2.2.4 Roche Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Roche Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Pediatric Orphan Drug Product and Services
    • 2.3.4 Novartis Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Pediatric Orphan Drug Product and Services
    • 2.4.4 Johnson & Johnson Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Johnson & Johnson Recent Developments/Updates
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Pediatric Orphan Drug Product and Services
    • 2.5.4 Pfizer Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pfizer Recent Developments/Updates
  • 2.6 Amgen
    • 2.6.1 Amgen Details
    • 2.6.2 Amgen Major Business
    • 2.6.3 Amgen Pediatric Orphan Drug Product and Services
    • 2.6.4 Amgen Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Amgen Recent Developments/Updates
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Pediatric Orphan Drug Product and Services
    • 2.7.4 Sanofi Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sanofi Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Pediatric Orphan Drug Product and Services
    • 2.8.4 AstraZeneca Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Takeda
    • 2.9.1 Takeda Details
    • 2.9.2 Takeda Major Business
    • 2.9.3 Takeda Pediatric Orphan Drug Product and Services
    • 2.9.4 Takeda Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Takeda Recent Developments/Updates
  • 2.10 Vertex Pharmaceuticals
    • 2.10.1 Vertex Pharmaceuticals Details
    • 2.10.2 Vertex Pharmaceuticals Major Business
    • 2.10.3 Vertex Pharmaceuticals Pediatric Orphan Drug Product and Services
    • 2.10.4 Vertex Pharmaceuticals Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Vertex Pharmaceuticals Recent Developments/Updates
  • 2.11 AbbVie
    • 2.11.1 AbbVie Details
    • 2.11.2 AbbVie Major Business
    • 2.11.3 AbbVie Pediatric Orphan Drug Product and Services
    • 2.11.4 AbbVie Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 AbbVie Recent Developments/Updates
  • 2.12 Biogen
    • 2.12.1 Biogen Details
    • 2.12.2 Biogen Major Business
    • 2.12.3 Biogen Pediatric Orphan Drug Product and Services
    • 2.12.4 Biogen Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Biogen Recent Developments/Updates
  • 2.13 Eli Lilly
    • 2.13.1 Eli Lilly Details
    • 2.13.2 Eli Lilly Major Business
    • 2.13.3 Eli Lilly Pediatric Orphan Drug Product and Services
    • 2.13.4 Eli Lilly Pediatric Orphan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Eli Lilly Recent Developments/Updates

3 Competitive Environment: Pediatric Orphan Drug by Manufacturer

  • 3.1 Global Pediatric Orphan Drug Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pediatric Orphan Drug Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pediatric Orphan Drug Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pediatric Orphan Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pediatric Orphan Drug Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pediatric Orphan Drug Manufacturer Market Share in 2025
  • 3.5 Pediatric Orphan Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Pediatric Orphan Drug Market: Region Footprint
    • 3.5.2 Pediatric Orphan Drug Market: Company Product Type Footprint
    • 3.5.3 Pediatric Orphan Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pediatric Orphan Drug Market Size by Region
    • 4.1.1 Global Pediatric Orphan Drug Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pediatric Orphan Drug Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pediatric Orphan Drug Average Price by Region (2021-2032)
  • 4.2 North America Pediatric Orphan Drug Consumption Value (2021-2032)
  • 4.3 Europe Pediatric Orphan Drug Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pediatric Orphan Drug Consumption Value (2021-2032)
  • 4.5 South America Pediatric Orphan Drug Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pediatric Orphan Drug Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pediatric Orphan Drug Sales Quantity by Type (2021-2032)
  • 5.2 Global Pediatric Orphan Drug Consumption Value by Type (2021-2032)
  • 5.3 Global Pediatric Orphan Drug Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pediatric Orphan Drug Sales Quantity by Application (2021-2032)
  • 6.2 Global Pediatric Orphan Drug Consumption Value by Application (2021-2032)
  • 6.3 Global Pediatric Orphan Drug Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pediatric Orphan Drug Sales Quantity by Type (2021-2032)
  • 7.2 North America Pediatric Orphan Drug Sales Quantity by Application (2021-2032)
  • 7.3 North America Pediatric Orphan Drug Market Size by Country
    • 7.3.1 North America Pediatric Orphan Drug Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pediatric Orphan Drug Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pediatric Orphan Drug Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pediatric Orphan Drug Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pediatric Orphan Drug Market Size by Country
    • 8.3.1 Europe Pediatric Orphan Drug Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pediatric Orphan Drug Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pediatric Orphan Drug Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pediatric Orphan Drug Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pediatric Orphan Drug Market Size by Region
    • 9.3.1 Asia-Pacific Pediatric Orphan Drug Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pediatric Orphan Drug Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pediatric Orphan Drug Sales Quantity by Type (2021-2032)
  • 10.2 South America Pediatric Orphan Drug Sales Quantity by Application (2021-2032)
  • 10.3 South America Pediatric Orphan Drug Market Size by Country
    • 10.3.1 South America Pediatric Orphan Drug Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pediatric Orphan Drug Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pediatric Orphan Drug Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pediatric Orphan Drug Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pediatric Orphan Drug Market Size by Country
    • 11.3.1 Middle East & Africa Pediatric Orphan Drug Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pediatric Orphan Drug Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pediatric Orphan Drug Market Drivers
  • 12.2 Pediatric Orphan Drug Market Restraints
  • 12.3 Pediatric Orphan Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pediatric Orphan Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pediatric Orphan Drug
  • 13.3 Pediatric Orphan Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pediatric Orphan Drug Typical Distributors
  • 14.3 Pediatric Orphan Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pediatric Orphan Drug. Industry analysis & Market Report on Pediatric Orphan Drug is a syndicated market report, published as Global Pediatric Orphan Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pediatric Orphan Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo